Cite
HARVARD Citation
Teerlink, J. et al. (2017). Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) study. European journal of heart failure. pp. 1520-1529. [Online].